Hoenlein Malcolm 4
4 · Fortress Biotech, Inc. · Filed Nov 30, 2018
Insider Transaction Report
Form 4
Hoenlein Malcolm
Director
Transactions
- Award
Common Stock
2018-01-01+50,000→ 285,000 total
Footnotes (2)
- [F1]One-third of the shares will vest on each January 1, 2019, 2020 and 2021, subject to continued service. The reporting person elected to defer 100% of these restricted shares pursuant to the issuer's Deferred Compensation Plan for Directors and instead received deferred share units that are subject to the same vesting conditions. Vested deferred shares will be delivered to the reporting person in January of the year following the reporting person's termination of service, or earlier upon his death or change in control of the issuer.
- [F2]The total holdings include 50,000 shares underlying deferred share units that were previously reported in Table II.